Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
TLK60596
print preview
bookmark
share with colleague
General Information
Company
Telik Inc.
Description
Dual VEGFR1 and VEGFR2 kinase inhibitor
Molecular Target
Vascular endothelial growth factor (VEGF) receptor 1 (FLT1) (VEGFR-1)
;
Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2)
Mechanism of Action
Latest Stage of Development
Preclinical
Indication
Colorectal cancer
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy